Promising safety results for SGLT-2s Several studies have shown encouraging results, like a 2022 study that found that among 134 participants with type 1 taking an SGLT-2 inhibitor, there were no instances of DKA during treatment
Playing and listening to tailor-made notched music: cortical plasticity induced by unimodal and multimodal training in tinnitus patients
Singh S, Priyadarshi A et al (2018) Pharmacognostical and phytochemical analysis of Pippali ( Piper longum Linn.)
Gutierrez-Merino J, Isla B, Combes T, Martinez-Estrada F, Maluquer De Motes C (2020) Beneficial bacteria activate type-I interferon production via the intracellular cytosolic sensors STING and MAVS
If constipation persists beyond six weeks despite lifestyle modifications, switching to oral semaglutide or exploring the Precision Peptide Genetic Test to identify peptide-pathway predispositions may help optimize your therapy